Toxic hepatitis and liver failure under therapy with flutamide;Ikterus und schwere Leberfunktionsstörung bei der hormonablativen Behandlung des Prostatakarzinoms

Internist

Volumn 45, Issue 3, 2004, Pages 333-340

  Lubbert C ^a   Wiese, M ^a   Haupt, R ^a   Ruf, B R ^a  

^a Klinikum St Georg   (Germany)

Author keywords

Flutamide; Hepatotoxicity; Liver failure; Prostatic cancer; Toxic hepatitis

Indexed keywords

FLUTAMIDE;

AGED; AUTOPSY; CASE REPORT; DISEASE COURSE; DRUG METABOLISM; DRUG WITHDRAWAL; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HEPATIC COMA; HEPATORENAL SYNDROME; HUMAN; LIVER DYSFUNCTION; LIVER FAILURE; LIVER FUNCTION; MALE; PROSTATE CANCER; REVIEW; TOXIC HEPATITIS;

AGED; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FATAL OUTCOME; FLUTAMIDE; HEPATITIS, TOXIC; HUMANS; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER FAILURE; LIVER FUNCTION TESTS; MALE; NEOPLASM STAGING; PREDNISOLONE; PROSTATIC NEOPLASMS;

EID: 12144290215     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-003-1114-2     Document Type: Review

References (34)

1. Alperine M, Cohen L, Cocheton JJ et al. (1991) Acute hepatitis caused by flutamide. Presse Med 20: 1459-1460
2. Altwein JE, Mohandessi B (2001) Das fortgeschrittene Prostatakarzinom - Endokrine Manipulation und Chemotherapie. Urologe 41: 386-402
3. Andrade RJ, Lucena MI, Fernandez MC et al. (1999) Fulminant liver failure associated with flutamide therapy for hirsutism. Lancet 353: 983
4. Chu CW, Hwang SJ, Luo JC et al. (1998) Flutamide-induced liver injury: a case report. Zhonghua Yi Xue Za Zhi 61: 678-682
5. Corkery JC, Bihrle W, McCaffrey JA et al. (1991) Flutamide-related fulminant hepatic failure. J Clin Gastroenterol 13: 364-365
6. Crownover RL, Holland J, Chen A et al. (1996) Flutamide-induced liver toxicity including fatal hepatic necrosis. Int J Radiat Oncol Biol Phys 34: 911-915
7. Cusan L, Dupont A, Belanger A et al. (1990) Treatment of hirsutism with the pure antiandrogen flutamide. J Am Acad Dermatol 23: 462-469
8. Dankoff JS (1992) Near fatal liver dysfunction secondary to administration of flutamide for prostate cancer. J Urol 148: 1914
9. Dourakis SP, Alexopoulou AA, Hadziyannis SJ (1994) Fulminant hepatitis after flutamide treatment. J Hepatol 20: 350-353
10. Fau D, Eugene D, Berson A et al. (1994) Toxicity of the antiandrogen flutamide in isolated rat hepatocytes. J Pharmacol Exp Ther 269: 954-962
11. Garía Cortés M, Andrade RJ, Lucena MI et al. (2001) Flutamide-induced hepatotoxicity: report of a case series. Rev Esp Enferm Dig 92: 428-432
12. Gomez JL, Dupont A,Cusan Let al. (1992) Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am J Med 92: 465-470
13. Hart W, Stricker BH (1989) Flutamide and hepatitis. Ann Intern Med 110: 943-944
14. Kozar Y, Sasmaz N, Oguz P et al. (1995) Hepatic insufficiency developing as a result of flutamide treatment. Am J Gastroenterol 90: 1027-1028
15. Kraus I, Vitezic D, Oguic R (2001) Flutamide-induced acute hepatitis in advanced prostate cancer patients. Int J Clin Pharmacol Ther 39: 395-399
16. Lee WM (1995) Drug-induced hepatitis. N Engl J Med 333: 1118-1127
17. Li AP, Kaminski DL, Rasmussen A (1995) Substrates of human hepatic cytochrome P450 3A4.Toxicology 104: 1-8
18. Moller S, Iversen P, Franzmann VB (1990) Flutamide-induced liver failure. J Hepatol 10: 346-349
19. Okaneya T, Murata Y, Kinebuchi Y (1999) Fatal hepatic failure following hepatitis caused by flutamide: a case report. Nippon Hinyokika Gakkai Zasshi 90: 590-593
20. Oosterlinck W, Casselmann J, Mattelaer J et al. (1996) Tolerability and safety of flutamide in monotherapy, with orchiectomy or with LH-Rh-analoga in advanced prostate cancer patients. Eur Urol 30: 458-463
21. Patel H, Rhee E, Zimmern PE (1996) Hepatic encephalopathy induced by flutamide administered for the treatment of prostatic cancer. J Urol 102: 123-125
22. Prattichizzo FA (1994) Acute cholestatic hepatitis secondary to flutamide treatment. Am J Med 96: 392
23. Radwanski E, Perentesis G, Symchowicz S et al. (1989) Single and multiple dose pharmacokinetic evaluation of flutamide in normal geriatric volunteers. J Clin Pharmacol 29: 554-558
24. Rodriguez Gomez SJ, Martinez Moreno J, Martin Arribas MI et al (2000) Fallo hepatico fulminante inducido por flutamida. Rev Esp Enferm Dig 92: 411
25. Rosenthal SA, Linstadt DE, Leihenhaut MH et al. (1996) Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer. Radiology 199: 451-455
26. Rosman AS, Frissora-Rodeo C,Marshall AT et al. (1993) Cholestatic hepatitis following flutamide. Dig Dis Sci 38: 1756-1759
27. Satoh T, Egawa E, Katsuta M et al. (1997) A case of fulminant hepatitis caused by antiandrogen, flutamide in a patient with prostate cancer. Nippon Hinyokika Gakkai Zasshi 88:694-696
28. Schütz E, Gummert J, Mohr F et al. (1993) Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipients. Lancet 341: 436
29. Schulz M, Schmoldt A, Donn F et al. (1988) The pharmacokinetic of flutamide and its major metabolites after single oral dose and during chronic treatment. Eur J Clin Pharmacol 34: 633-636
30. Teschke R (2002) Arzneimittelbedingte Lebererkrankungen. Z Gastroenterol 40: 305-326
31. Wietzke P et al. (1997) Hepatotoxizität von Flutamid. Z Gastroenterol 35: 631-635
32. Wrighton SA, Stevens JC (1992) The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 22: 1-21
33. Wysowski DK, Freimann JP, Tourtelot JB et al. (1993) Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med 118: 860-864
34. Wysowski DK, Fourcroy JL (1996) Flutamide hepatotoxicity. J Urol 155: 209-212